Sonodynamic therapy (SDT) offers a noninvasive route for deep-seated tumors, yet its efficacy is hindered by low energy density and the transient nature of ultrasound-induced reactive oxygen species (ROS). This review introduces a paradigm shift, conceptualizing metal-organic frameworks (MOFs) not merely as passive sensitizers, but as precision sonoreactors. By deconstructing the therapeutic process into a hierarchical system of acoustic energy harvesting, signal transduction, and catalytic ROS evolution, the study outlines how the unique coordinative architectures of MOFs can orchestrate programmable energy conversion. This mechanism-driven approach transcends traditional empirical optimization, offering a unified theoretical framework to overcome tumor microenvironment barriers and achieve sustained, lineage-specific ROS generation for enhanced therapeutic outcomes.
Conventional sonodynamic therapy (SDT) relies on the rapid generation of reactive oxygen species (ROS) upon ultrasound irradiation. However, the low energy density of ultrasound and the transient nature of the resulting charge excitations limit the total yield of ROS. Furthermore, the therapy-resistant tumormicroenvironment (TME), characterized by severe hypoxia, elevated glutathione (GSH) levels, and a dense stromal architecture, rapidly quenches these reactive species, significantly attenuating their biological effects. Existing strategies often focus on isolated material parameters, failing to address the systemic suppression imposed by the TME. Based on these challenges, or due to these problems, in-depth research on orchestrating robust and sustained oxidative cascades through precision-engineered nanostructures is urgently needed.
In a review (DOI: 10.1021/prechem.6c00075) available online October 13, 2026 in Precision Chemistry , researchers from the Hefei National Research Center for Physical Sciences at the Microscale, University of Science and Technology of China, detailed a mechanism-driven design framework for next-generation sonodynamic platforms. The review, authored by Jiawei Kang, Chenyang Bi, Qianwang Chen, and Dongdong Wang, systematically elucidates the intrinsic relationships among acoustic response, charge transfer, and catalytic reactions within metal-organic frameworks (MOFs). By shifting the perspective from materials optimization to reaction process programming, the team proposes a clear mechanistic landscape for constructing highly efficient sonoresponsive therapeutic systems.
The review deconstructs MOF-mediated SDT into a highly coupled three-component system: a sonic energy harvester, a signal transducer, and a catalytic reactor. First, the ultrahigh surface area and nanoporous structure of MOFs act as cavitation nuclei, lowering the energy barrier for bubble collapse. Second, these localized acoustic energies are converted into electronic responses via sonoluminescence-driven excitation and mechanically induced piezoelectric polarization. The diverse charge transfer modes within the frameworks—including ligand-to-metal charge transfer (LMCT) and metal-to-ligand charge transfer (MLCT)—dictate the separation of these charges. Finally, the metal nodes serve as redox-active centers, catalyzing the transformation of charge carriers into specific primary reactive oxygen species, such as hydroxyl radicals (•OH) and singlet oxygen (1O2). Crucially, the ordered framework suppresses charge recombination while confined microenvironments enrich substrates. Furthermore, this dynamic network drives TME reprogramming through four interconnected cascade cycles: a Fenton amplification cycle, a redox-collapse cycle, an oxygen self-sustaining cycle, and a lipid peroxidation amplification cycle. These cascades amplify oxidative stress, alleviate hypoxia, and trigger immunogenic cell death (ICD), paving the way for synergistic combinations with immunotherapy.
The authors explained that the role of MOFs extends far beyond that of conventional sonosensitizers, encompassing broader functions such as energy transduction and microenvironment modulation. They said future progress in this field depends on a deeper mechanistic understanding across multiple length and time scales. They emphasized that developing advanced operando characterization techniques combined with theoretical modeling will be crucial for guiding the rational design of next-generation systems. They added that by regulating cavitation phenomena and exploring diverse energy-transduction mechanisms, researchers can achieve precise control over the entire acoustic-to-chemical energy conversion process, transforming theoretical concepts into viable clinical platforms.
This comprehensive framework holds substantial implications for the precise treatment of deep-seated and large solid tumors. By explicitly linking acoustic input, charge-carrier dynamics, and biological responses, the proposed mechanism-driven design principles enable the rational engineering of MOF-based platforms. Beyond primary tumor ablation, these precision sonoreactors can synergize with various modalities—such as photothermal therapy, starvation therapy, and immune checkpoint blockade—to eradicate metastatic lesions and establish systemic immunological memory. Moving forward, the integration of standardized acoustic dosimetry, scalable manufacturing, and rigorous assessments of biological fate will be essential to bridge the gap between laboratory research and clinical application, ultimately accelerating the translation of MOF-based SDT.